| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/30/2023 | 8.71% | Baird | $67 → $69 | Maintains | Outperform |
| 06/28/2023 | 3.99% | Citigroup | → $66 | Initiates Coverage On | → Neutral |
| 06/01/2023 | 10.29% | Morgan Stanley | $71 → $70 | Maintains | Overweight |
| 04/20/2023 | 11.86% | Morgan Stanley | $70 → $71 | Maintains | Overweight |
| 03/02/2023 | 10.29% | Morgan Stanley | $66 → $70 | Maintains | Overweight |
| 12/01/2022 | 3.99% | Morgan Stanley | $63 → $66 | Maintains | Overweight |
| 12/01/2022 | 3.99% | Baird | $59 → $66 | Maintains | Outperform |
| 09/01/2022 | -7.04% | Baird | $61 → $59 | Maintains | Outperform |
| 07/18/2022 | -0.74% | Morgan Stanley | $68 → $63 | Maintains | Overweight |
| 07/18/2022 | -19.65% | Stifel | $53 → $51 | Maintains | Hold |
| 06/02/2022 | 7.14% | Morgan Stanley | $73 → $68 | Maintains | Overweight |
| 06/02/2022 | -3.89% | Baird | $65 → $61 | Maintains | Outperform |
| 10/13/2021 | 15.01% | Morgan Stanley | $75 → $73 | Maintains | Overweight |
| 09/03/2021 | 18.17% | Morgan Stanley | $79 → $75 | Maintains | Overweight |
| 07/13/2021 | 24.47% | Morgan Stanley | $75 → $79 | Maintains | Overweight |
| 06/03/2021 | 18.17% | Morgan Stanley | $73 → $75 | Maintains | Overweight |
| 04/12/2021 | 15.01% | Morgan Stanley | $74 → $73 | Maintains | Overweight |
| 02/26/2021 | 16.59% | Morgan Stanley | $73 → $74 | Maintains | Overweight |
| 01/22/2021 | 15.01% | Morgan Stanley | $68 → $73 | Maintains | Overweight |
| 12/15/2020 | 7.14% | Morgan Stanley | $64 → $68 | Maintains | Overweight |
| 12/04/2020 | 0.84% | Morgan Stanley | $60 → $64 | Maintains | Overweight |
| 10/02/2020 | -11.77% | Baird | → $56 | Upgrades | Neutral → Outperform |
| 06/26/2020 | -5.47% | Morgan Stanley | → $60 | Initiates Coverage On | → Overweight |
| 06/03/2020 | -22.8% | Stifel | $44 → $49 | Maintains | Hold |
| 03/19/2020 | -30.68% | Stifel | $50 → $44 | Maintains | Hold |
| 03/06/2020 | -25.95% | Baird | $49 → $47 | Maintains | Neutral |
| 09/14/2018 | -5.47% | Stifel | $54 → $60 | Maintains | Hold |
| 09/07/2018 | -14.92% | Stifel | $46 → $54 | Maintains | Hold |
What is the target price for Donaldson (DCI)?
The latest price target for Donaldson (NYSE: DCI) was reported by Baird on August 30, 2023. The analyst firm set a price target for $69.00 expecting DCI to rise to within 12 months (a possible 8.71% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Donaldson (DCI)?
The latest analyst rating for Donaldson (NYSE: DCI) was provided by Baird, and Donaldson maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Donaldson (DCI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Donaldson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Donaldson was filed on August 30, 2023 so you should expect the next rating to be made available sometime around August 30, 2024.
Is the Analyst Rating Donaldson (DCI) correct?
While ratings are subjective and will change, the latest Donaldson (DCI) rating was a maintained with a price target of $67.00 to $69.00. The current price Donaldson (DCI) is trading at is $63.47, which is out of the analyst's predicted range.
